Fluid Management in Liver Failure-Reference-Cited by-同舟云学术

Fluid Management in Liver Failure

Published:2023-11-30 Issue: Volume: Page:411-425
ISSN:
Container-title:Rational Use of Intravenous Fluids in Critically Ill Patients
language:
Short-container-title:

Author:

Mekeirele Michaël,Wilmer Alexander

Abstract

AbstractIn this chapter, fluid management in both acute and acute-on chronic liver failure is discussed. For each pathology, the specific hemodynamic alterations are first described and followed by some general and specific considerations during hemodynamic optimization and evidence-based guidance in the choice of fluids.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-42205-8_21

Reference40 articles.

1. Weiss E, Paugam-Burtz C, Jaber S. Shock etiologies and fluid management in liver failure. Semin Respir Crit Care Med. 2018;39(5):538–45.

2. Bernardi M, Angeli P, Claria J, Moreau R, Gines P, Jalan R, et al. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut. 2020;69(6):1127–38.

3. Caraceni P, Domenicali M, Tovoli A, Napoli L, Ricci CS, Tufoni M, et al. Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med. 2013;24(8):721–8.

4. Jalan R, Schnurr K, Mookerjee RP, Sen S, Cheshire L, Hodges S, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 2009;50(2):555–64.

5. Thévenot T, Bureau C, Oberti F, Anty R, Louvet A, Plessier A, et al. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. J Hepatol. 2015;62(4):822–30.